Cullmann W, Büscher K H, Opferkuch W
Immun Infekt. 1986 Nov;14(6):227-9.
Imipenem-resistant variants can be selected from clinical Pseudomonas aeruginosa isolates in a frequency of 10(-8) to 10(-7) and 10(-5) in a single strain. In any case, there was no cross resistance between imipenem and other beta-lactams. In all IMI variants the induction potency of imipenem for the chromosomally-mediated Id beta-lactamase was markedly diminished as compared to the corresponding parent strains. Moreover, in all imipenem-resistant variants as well as in imipenem-resistant clinical isolates phenotypic expression of either a 46,000 dalton or a 47,000 dalton outer membrane protein was marginal; these proteins could be identified as proteins D1 and D2. These findings suggest a penetration barrier responsible for imipenem-resistance in Pseudomonas aeruginosa.
耐亚胺培南的变异株可从临床铜绿假单胞菌分离株中以10^(-8)至10^(-7)的频率选出,单一菌株中可达10^(-5)。无论如何,亚胺培南与其他β-内酰胺类药物之间不存在交叉耐药性。在所有亚胺培南变异株中,与相应亲本菌株相比,亚胺培南对染色体介导的Idβ-内酰胺酶的诱导能力明显降低。此外,在所有耐亚胺培南变异株以及耐亚胺培南临床分离株中,46000道尔顿或47000道尔顿外膜蛋白的表型表达都很微弱;这些蛋白可鉴定为蛋白D1和D2。这些发现提示存在一种导致铜绿假单胞菌对亚胺培南耐药的渗透屏障。